Patel Samir Rashmikant 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-04 4:44 pm Purchase | 2026-03-02 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Patel Samir Rashmikant | 243,130,375 10.400% | 99,484,521 (+69.26%) | Filing |
| 2024-12-06 4:00 pm Purchase | 2024-11-14 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Patel Samir Rashmikant | 143,645,854 10.850% | 58,316,800 (+68.34%) | Filing |
| 2024-06-07 6:00 pm Purchase | 2024-05-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | Patel Samir Rashmikant | 85,329,054 14.500% | 85,319,226 (+868123.99%) | Filing |